
Bioorganic and Medicinal Chemistry Letters p. 805 - 810 (1997)
Update date:2022-09-26
Topics:
Padia
Chilvers
Daum
Pinnock
Suman-Chauhan
Webdale
Trivedi
A novel hybrid series of nonpeptide CCK-B receptor antagonists has been designed from two known series derived from asperlicin. An efficient synthesis of 2-aminoquinazolinone, an intermediate for the synthesis of a targeted analog, has been developed.
View MoreShijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
Contact:86-575-86132822,86-575-86085355
Address:No.418 Dadao West Road,Qixing Street,Xinchang, Zhejiang Province, China.
SHENYANG COMEBOARD TECHNOLOGY CO., LTD
Contact:+86-24-25724626
Address:Room2210,Tianbao International Building,No.8-1 Weigong South Street,Tiexi District,Shenyang,China
Chengdu ZY Biochemical Technology Co., LTD
Contact:0086-28-88680086
Address:170 Qingpu Road, Shouan Town, Pujiang County
Ji'nan Orgachem Pharmaceutical Co.,Ltd
Contact:+86-531-82687810
Address:Jinan
Doi:10.1021/jo980084i
(1998)Doi:10.1248/cpb.15.1990
(1967)Doi:10.1016/j.jfluchem.2007.03.002
(2007)Doi:10.1021/acs.jmedchem.7b01282
(2018)Doi:10.1016/S0040-4020(98)00508-0
(1998)Doi:10.1039/a708245b
(1998)